May direct-acting antiviral regimens for chronic hepatitis C virus infections have neuropsychiatric adverse drug reactions? A pilot study conducted in patients receiving sofosbuvir-based regimens in the real-life setting
Crossref DOI link: https://doi.org/10.1007/s40267-017-0422-x
Published Online: 2017-07-06
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Simeone, Davide http://orcid.org/0000-0002-1623-777X
Spera, Anna Maria
Tosone, G.
Orlando, R.
License valid from 2017-07-06